Serina Therapeutics, Inc.(SER)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SER Serina Therapeutics, Inc.

盘后交易 10-09 17:05:01 EDT

2.00

-0.01

-0.50%

最高2.05	最低1.99	成交量2.23万
今开1.99	昨收2.01	日振幅2.99%
总市值5,080万	流通市值2,296万	总股本2,540万
成交额4.47万	换手率0.19%	流通股本1,148万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SER","market":"US","secType":"STK","nameCN":"Serina Therapeutics, Inc.","latestPrice":2,"timestamp":1791576000000,"preClose":2.01,"halted":0,"volume":22273,"delay":0,"changeRate":-0.004975124378109347,"floatShares":11482448,"shares":25400500,"eps":-1.93037,"marketStatus":"盘后交易","change":-0.01,"latestTime":"10-09 17:05:01 EDT","open":1.99,"high":2.05,"low":1.99,"amount":44743,"amplitude":0.029851,"askPrice":2.26,"askSize":100,"bidPrice":1.9,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-1.93037,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791590400000},"marketStatusCode":4,"adr":0,"exchange":"AMEX","adjPreClose":2.01,"preHourTrading":{"tag":"盘前","latestPrice":2.0099,"preClose":2.01,"latestTime":"07:21 EDT","volume":17,"amount":34.1688967,"timestamp":1791544891627,"change":-0.0001,"changeRate":-0.00005,"amplitude":0.000149},"volumeRatio":0.912656},"requestUrl":"/m/hq/s/SER","defaultTab":"news","newsList":[{"id":"1127143858","title":"Serina Therapeutics Inc：公布Ser-252注册研究晚期帕金森病队列1观察结果，并推进至队列2","url":"https://stock-news.laohu8.com/highlight/detail?id=1127143858","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127143858?lang=zh_cn&edition=full","pubTime":"2026-09-09 19:45","pubTimestamp":1788954311,"startTime":"0","endTime":"0","summary":"Serina Therapeutics Inc近日宣布，其针对晚期帕金森病开展的Ser-252注册研究已完成队列1的观察，并正式迈入队列2阶段。\n该公司披露，在Ser-252注册研究中，队列1的数据收集与初步评估已告一段落，相关观察结果现已对外公布。基于这些正面发现，研究团队决定将试验推进至下一阶段——队列2。\n这一进展标志着该候选疗法在治疗晚期帕金森病方面的临床开发取得了阶段性成果。Serina Therapeutics正稳步推进其研究计划，力求为这一难治性神经退行性疾病带来新的治疗选择。\n随着研究进入队列2，公司将继续评估Ser-252的安全性与疗效，为后续的注册申请积累关键临床证据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163003272","title":"Serina Therapeutics预计2027年上半年公布单次递增剂量研究部分的顶线数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1163003272","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163003272?lang=zh_cn&edition=full","pubTime":"2026-09-09 19:45","pubTimestamp":1788954308,"startTime":"0","endTime":"0","summary":"Serina Therapeutics公司宣布，其单次递增剂量研究部分的顶线数据预计将在2027年上半年发布。这一时间表的确认，标志着该公司在临床开发进程中迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175817851","title":"Serina Therapeutics与Roth Principal Investments达成股票购买协议（2026年8月21日，SEC文件披露）","url":"https://stock-news.laohu8.com/highlight/detail?id=1175817851","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175817851?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:04","pubTimestamp":1787825058,"startTime":"0","endTime":"0","summary":"Serina Therapeutics, Inc.于2026年8月21日宣布，已与Roth Principal Investments签署股票购买协议。此次合作的具体条款虽未完全公开，但市场分析人士普遍认为，这一动作将有助于增强Serina Therapeutics的财务灵活性，并为其研发管线及商业化进程注入新的动力。此次与Roth Principal Investments的联手，可能预示着公司即将加速推进关键临床试验或扩大生产能力。截至目前，Serina Therapeutics尚未就协议细节发布进一步评论，但SEC文件已确认交易的有效性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132856464","title":"Serina Therapeutics：Roth Principal Investments拟发售最多1250万股普通股——SEC文件揭示","url":"https://stock-news.laohu8.com/highlight/detail?id=1132856464","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132856464?lang=zh_cn&edition=full","pubTime":"2026-08-25 05:29","pubTimestamp":1787606984,"startTime":"0","endTime":"0","summary":"Serina Therapeutics, Inc. 披露了一项重大股权运作计划。根据美国证券交易委员会最新提交的文件，Roth Principal Investments 拟发售该公司高达12,500,000股的普通股。这一消息源自Serina Therapeutics提交的监管文件，揭示了重要投资者可能进行的股权变动。SEC文件显示，该发售计划由Roth Principal Investments主导。不过，文件并未详细说明发售的具体时间表或定价条款。市场观察人士正密切关注这一动态，以评估其对Serina Therapeutics股价和公司治理的潜在影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132634472","title":"Serina Therapeutics宣布Ser-252治疗晚期帕金森病注册试验第一队列入组及给药完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1132634472","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132634472?lang=zh_cn&edition=full","pubTime":"2026-07-23 18:01","pubTimestamp":1784800882,"startTime":"0","endTime":"0","summary":"Serina Therapeutics宣布，其针对晚期帕金森病的在研药物Ser-252的注册试验，已完成第一患者队列的入组与给药工作。这一进展标志着该关键性临床研究向前迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176798581","title":"Serina Therapeutics宣布Ser-252用于晚期帕金森病的1B期注册试验队列1哨点给药完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1176798581","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176798581?lang=zh_cn&edition=full","pubTime":"2026-07-10 00:13","pubTimestamp":1783613597,"startTime":"0","endTime":"0","summary":"Serina Therapeutics宣布，其用于治疗晚期帕金森病的候选药物Ser-252，其1B期注册试验第一队列的哨点给药阶段现已顺利完成。这一进展标志着该药物临床开发过程中的一个重要节点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169771277","title":"Serina Therapeutics公司提交文件，拟注册出售股东至多1650万股普通股的转售计划 - 美国证券交易委员会备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1169771277","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169771277?lang=zh_cn&edition=full","pubTime":"2026-05-23 04:03","pubTimestamp":1779480194,"startTime":"0","endTime":"0","summary":"Serina Therapeutics公司已向美国证券交易委员会提交文件，申请注册由出售股东转售的至多1650万股普通股。此次备案旨在为现有股东的股份出售提供注册便利，使其能够在公开市场进行合规转让。根据提交的文件，拟转售的股份数量最高可达1650万股，具体出售时间、价格及数量将由相关股东根据市场情况自行决定。该注册声明生效后，相关股东即可根据声明条款在市场上出售其持有的公司普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137463093","title":"Serina Therapeutics：Ser-252针对晚期帕金森病的1B期注册研究已启动；关键数据目标定于2027年上半年","url":"https://stock-news.laohu8.com/highlight/detail?id=1137463093","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137463093?lang=zh_cn&edition=full","pubTime":"2026-05-15 05:46","pubTimestamp":1778795203,"startTime":"0","endTime":"0","summary":"Serina Therapeutics公司宣布，其针对晚期帕金森病的研究性疗法Ser-252，其1B期注册研究现已启动。这项研究旨在评估该疗法的安全性与有效性，公司计划在2027年上半年获得关键数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516038266","title":"Serina Therapeutics, Inc.盘中异动 股价大跌6.28%报4.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516038266","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516038266?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:12","pubTimestamp":1741101121,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时12分，Serina Therapeutics, Inc.股票出现波动，股价大幅跳水6.28%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段生物技术公司，开发用于治疗神经系统疾病和疼痛的全资候选药物管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304231201abe7fbde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304231201abe7fbde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SER","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512660681","title":"Serina Therapeutics, Inc.盘中异动 早盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512660681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512660681?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:05","pubTimestamp":1739891102,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时05分，Serina Therapeutics, Inc.股票出现异动，股价快速上涨5.09%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Solid Biosciences Inc.、Allogene Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为333.24%、127.72%、119.52%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.，振幅分别为41.79%、34.04%、33.21%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段生物技术公司，开发用于治疗神经系统疾病和疼痛的全资候选药物管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218230502a24ab443&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218230502a24ab443&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511948626","title":"Serina Therapeutics, Inc.盘中异动 早盘大幅拉升8.56%报5.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511948626","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511948626?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:13","pubTimestamp":1739546029,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时13分，Serina Therapeutics, Inc.股票出现异动，股价大幅上涨8.56%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2318.30%、605.57%、466.37%，振幅较大的相关个股有Moleculin Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Cns Pharmaceuticals, Inc.，振幅分别为66.93%、43.67%、40.35%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段生物技术公司，开发用于治疗神经系统疾病和疼痛的全资候选药物管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021423134996232542&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021423134996232542&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509249111","title":"Serina Therapeutics, Inc.盘中异动 股价大跌5.91%报4.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509249111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509249111?lang=zh_cn&edition=full","pubTime":"2025-02-05 05:00","pubTimestamp":1738702800,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日05时00分，Serina Therapeutics, Inc.股票出现波动，股价大幅下跌5.91%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.44%。其相关个股中，Mink Therapeutics, Inc.、Cingulate Inc C/Wts 10/12/2026 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1973.19%、998.32%、593.04%，振幅较大的相关个股有Azitra Inc、Mink Therapeutics, Inc.、Omega Therapeutics, Inc.，振幅分别为123.99%、80.03%、60.13%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段生物技术公司，开发用于治疗神经系统疾病和疼痛的全资候选药物管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205050000a2397027&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205050000a2397027&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SER","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508914257","title":"Serina Therapeutics, Inc.盘中异动 股价大涨5.11%报4.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508914257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508914257?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:20","pubTimestamp":1738596029,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时20分，Serina Therapeutics, Inc.股票出现异动，股价快速拉升5.11%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.17%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为528.17%、409.28%、297.24%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为144.50%、75.23%、50.76%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段生物技术公司，开发用于治疗神经系统疾病和疼痛的全资候选药物管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203232029abc111ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203232029abc111ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SER","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508998137","title":"Serina Therapeutics, Inc.盘中异动 股价大涨5.33%报4.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508998137","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508998137?lang=zh_cn&edition=full","pubTime":"2025-02-01 01:16","pubTimestamp":1738343803,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日01时16分，Serina Therapeutics, Inc.股票出现异动，股价急速拉升5.33%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.62%。其相关个股中，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd.、Silexion Therapeutics Corp较为活跃，换手率分别为2353.47%、1965.22%、188.87%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为80.00%、56.30%、53.03%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段生物技术公司，开发用于治疗神经系统疾病和疼痛的全资候选药物管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201011644abbe5869&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201011644abbe5869&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507620113","title":"Serina Therapeutics, Inc.盘中异动 早盘股价大涨6.26%报4.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507620113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507620113?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:09","pubTimestamp":1738249741,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时09分，Serina Therapeutics, Inc.股票出现波动，股价急速上涨6.26%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Tectonic Therapeutic, Inc.、Kazia Therapeutics Limited、Alterity Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃，换手率分别为1298.90%、171.61%、170.93%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Alterity Therapeutics Limited、Kazia Therapeutics Limited，振幅分别为56.41%、49.83%、42.03%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段生物技术公司，开发用于治疗神经系统疾病和疼痛的全资候选药物管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130230901a2345bd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130230901a2345bd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505104277","title":"Serina Therapeutics, Inc.盘中异动 早盘快速上涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505104277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505104277?lang=zh_cn&edition=full","pubTime":"2025-01-21 23:11","pubTimestamp":1737472268,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日23时11分，Serina Therapeutics, Inc.股票出现波动，股价急速拉升5.41%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.24%。其相关个股中，Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Replimune Group, Inc.涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为692.06%、204.72%、171.38%，振幅较大的相关个股有Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Genelux Corporation，振幅分别为92.63%、38.48%、22.36%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段生物技术公司，开发用于治疗神经系统疾病和疼痛的全资候选药物管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121231108a22a6072&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121231108a22a6072&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SER","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504160249","title":"Serina Therapeutics, Inc.盘中异动 早盘股价大涨7.79%报5.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504160249","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504160249?lang=zh_cn&edition=full","pubTime":"2025-01-17 23:08","pubTimestamp":1737126538,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日23时08分，Serina Therapeutics, Inc.股票出现异动，股价快速上涨7.79%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.58%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段生物技术公司，开发用于治疗神经系统疾病和疼痛的全资候选药物管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117230859abaeb949&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117230859abaeb949&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SER"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503640497","title":"Serina Therapeutics, Inc.盘中异动 大幅上涨7.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503640497","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503640497?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:58","pubTimestamp":1736953080,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时58分，Serina Therapeutics, Inc.股票出现波动，股价大幅拉升7.76%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。其相关个股中，Dermata Therapeutics Inc C/Wts 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Exicure, Inc.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为196.35%、116.22%、36.61%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Mustang Bio, Inc.、Eterna Therapeutics Inc.，振幅分别为54.40%、30.18%、25.92%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段生物技术公司，开发用于治疗神经系统疾病和疼痛的全资候选药物管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115225801a223051a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115225801a223051a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SER","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502879378","title":"深圳市天威讯取得一种抗多径衰落的 SER 天线专利","url":"https://stock-news.laohu8.com/highlight/detail?id=2502879378","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502879378?lang=zh_cn&edition=full","pubTime":"2025-01-11 16:40","pubTimestamp":1736584840,"startTime":"0","endTime":"0","summary":"金融界 2025 年 1 月 11 日消息，国家知识产权局信息显示，深圳市天威讯无线技术有限公司取得一项名为“一种抗多径衰落的 SER 天线”的专利，授权公告号 CN 119135233 B，申请日期为 2024 年 11 月 。天眼查资料显示，深圳市天威讯无线技术有限公司，成立于2012年，位于深圳市，是一家以从事批发业为主的企业。企业注册资本1100万人民币，实缴资本1030万人民币。通过天眼查大数据分析，深圳市天威讯无线技术有限公司知识产权方面有商标信息1条，专利信息32条，此外企业还拥有行政许可9个。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/11164047370256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SER","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502770486","title":"Serina Therapeutics, Inc.盘中异动 早盘股价大涨5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502770486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502770486?lang=zh_cn&edition=full","pubTime":"2025-01-08 23:11","pubTimestamp":1736349093,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日23时11分，Serina Therapeutics, Inc.股票出现异动，股价急速上涨5.43%。Serina Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大，Silo Pharma, Inc.、60 Degrees Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为2441.54%、559.63%、527.73%，振幅较大的相关个股有Sana Biotechnology, Inc.、Silo Pharma, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为154.55%、139.44%、68.53%。Serina Therapeutics, Inc.公司简介：Serina Therapeutics Inc 是一家临床阶段生物技术公司，开发用于治疗神经系统疾病和疼痛的全资候选药物管线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010823113395fd0745&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010823113395fd0745&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SER","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.serinatx.com","stockEarnings":[{"period":"1week","weight":0.0308},{"period":"1month","weight":-0.196},{"period":"3month","weight":-0.0607},{"period":"6month","weight":0.0152},{"period":"1year","weight":-0.643},{"period":"ytd","weight":0.0507}],"compareEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":0.0104},{"period":"3month","weight":0.0251},{"period":"6month","weight":0.139},{"period":"1year","weight":0.1498},{"period":"ytd","weight":0.1349}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Serina Therapeutics, Inc.于2017年1月在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，正在开发一系列全资候选药物，用于治疗神经系统疾病和其他适应症。该公司的POZ药物递送技术旨在使某些现有药物和新型候选药物能够进行修改，从而有可能提高包括小分子、基于RNA的疗法和基于抗体的药物偶联物在内的多种药物的综合疗效和安全性。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.123641},{"month":2,"riseRate":0.375,"avgChangeRate":-0.090531},{"month":3,"riseRate":0.625,"avgChangeRate":0.019814},{"month":4,"riseRate":0.375,"avgChangeRate":-0.064978},{"month":5,"riseRate":0.375,"avgChangeRate":-0.050188},{"month":6,"riseRate":0.75,"avgChangeRate":0.13061},{"month":7,"riseRate":0.375,"avgChangeRate":-0.035337},{"month":8,"riseRate":0.25,"avgChangeRate":-0.073004},{"month":9,"riseRate":0.125,"avgChangeRate":-0.11217},{"month":10,"riseRate":0.5,"avgChangeRate":0.066086},{"month":11,"riseRate":0.142857,"avgChangeRate":-0.13511},{"month":12,"riseRate":0.375,"avgChangeRate":-0.03882}],"exchange":"AMEX","name":"Serina Therapeutics, Inc.","nameEN":"Serina Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Serina Therapeutics, Inc.(SER)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Serina Therapeutics, Inc.(SER)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Serina Therapeutics, Inc.,SER,Serina Therapeutics, Inc.股票,Serina Therapeutics, Inc.股票老虎,Serina Therapeutics, Inc.股票老虎国际,Serina Therapeutics, Inc.行情,Serina Therapeutics, Inc.股票行情,Serina Therapeutics, Inc.股价,Serina Therapeutics, Inc.股市,Serina Therapeutics, Inc.股票价格,Serina Therapeutics, Inc.股票交易,Serina Therapeutics, Inc.股票购买,Serina Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Serina Therapeutics, Inc.(SER)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Serina Therapeutics, Inc.(SER)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}